+検索条件
-Structure paper
タイトル | Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir. |
---|---|
ジャーナル・号・ページ | Nat Commun, Vol. 14, Issue 1, Page 6710, Year 2023 |
掲載日 | 2023年10月23日 |
![]() | Jérémie Prévost / Yaozong Chen / Fei Zhou / William D Tolbert / Romain Gasser / Halima Medjahed / Manon Nayrac / Dung N Nguyen / Suneetha Gottumukkala / Ann J Hessell / Venigalla B Rao / Edwin Pozharski / Rick K Huang / Doreen Matthies / Andrés Finzi / Marzena Pazgier / ![]() ![]() |
PubMed 要旨 | The HIV-1 entry inhibitor temsavir prevents the viral receptor CD4 (cluster of differentiation 4) from interacting with the envelope glycoprotein (Env) and blocks its conformational changes. To do ...The HIV-1 entry inhibitor temsavir prevents the viral receptor CD4 (cluster of differentiation 4) from interacting with the envelope glycoprotein (Env) and blocks its conformational changes. To do this, temsavir relies on the presence of a residue with small side chain at position 375 in Env and is unable to neutralize viral strains like CRF01_AE carrying His375. Here we investigate the mechanism of temsavir resistance and show that residue 375 is not the sole determinant of resistance. At least six additional residues within the gp120 inner domain layers, including five distant from the drug-binding pocket, contribute to resistance. A detailed structure-function analysis using engineered viruses and soluble trimer variants reveals that the molecular basis of resistance is mediated by crosstalk between His375 and the inner domain layers. Furthermore, our data confirm that temsavir can adjust its binding mode to accommodate changes in Env conformation, a property that likely contributes to its broad antiviral activity. |
![]() | ![]() ![]() ![]() |
手法 | EM (単粒子) |
解像度 | 2.96 - 3.2 Å |
構造データ | EMDB-27103, PDB-8czz: EMDB-27596, PDB-8dok: EMDB-29783, PDB-8g6u: EMDB-41613, PDB-8ttw: |
化合物 | ![]() ChemComp-83J: ![]() ChemComp-NAG: |
由来 |
|
![]() | VIRAL PROTEIN/INHIBITOR / T/F100 SOSIP / Clade A/E HIV-1 / 8ANC195 / 10-1074 / BMS-626529 / Temsavir / LMHS mutant. / VIRAL PROTEIN-INHIBITOR complex / VIRAL PROTEIN/IMMUNE SYSTEM / bnAbs / VIRAL PROTEIN-IMMUNE SYSTEM complex / VIRAL PROTEIN/INHIBITOR/IMMUNE SYSTEM / BG505 SOSIP / VIRAL PROTEIN-INHIBITOR-IMMUNE SYSTEM complex |